Eva Szentgyorgyi

Toronto, ON, CA 
Toronto, ON, CA 

Overview

Eva Szentgyorgyi practices practicing medicine in Toronto, Canada.

Her clinical expertise encompasses Cerebral Hypoxia, Celiac Disease, Malabsorption, and Type 1 Diabetes (T1D).

She is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Toronto, ON, Canada
Other Locations
Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
Enrollment Status: Completed
Publish Date: June 25, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
18F-Fluoroazomycin Arabinoside (FAZA) Positron Emission Tomography/Magnetic Imaging Resonance (PET/MRI) as a Biomarker of Hypoxia in Rectal Cancer: A Pilot Study
18F-Fluoroazomycin Arabinoside (FAZA) Positron Emission Tomography/Magnetic Imaging Resonance (PET/MRI) as a Biomarker of Hypoxia in Rectal Cancer: A Pilot Study
Enrollment Status: Completed
Publish Date: August 16, 2019
View 1 Less Clinical Trial

11 Total Publications

Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.
Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 16, 2017

Frequently Asked Questions about Eva Szentgyorgyi

Is Eva Szentgyorgyi a top-rated expert for Cerebral Hypoxia?

MediFind is an objective health platform that identifies experts based on real-world data. Eva Szentgyorgyi is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Eva Szentgyorgyi participate in research or clinical trials?

Yes. Eva Szentgyorgyi has published 11 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Eva Szentgyorgyi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Szentgyorgyi's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile